PeptideMeter result on a Tianjin retatrutide lot lands 3.7 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 13 of 48 of this archive, newest first.
A reminder that a purity figure is the output of a method, and that methods differ.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.
The supplier has not disputed the finding. It has not explained the gap either.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
The supplier has not disputed the finding. It has not explained the gap either.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The supplier has not disputed the finding. It has not explained the gap either.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Follow the resin, not the catalogue.
A reminder that a purity figure is the output of a method, and that methods differ.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.